Advertisement

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

      Abstract

      Background & Aims: The probiotic compound, VSL#3, is efficacious as maintenance therapy in pouchitis and ulcerative colitis. The aim of this study was to determine the efficacy of VSL#3 as a primary therapy in the treatment of colitis in the interleukin (IL)-10 gene-deficient mouse. Mechanisms of action of VSL#3 were investigated in T84 monolayers. Methods: IL-10 gene-deficient and control mice received 2.8 × 108 colony-forming units per day of VSL#3 for 4 weeks. Colons were removed and analyzed for cytokine production, epithelial barrier function, and inflammation. VSL#3 or conditioned media was applied directly to T84 monolayers. Results: Treatment of IL-10 gene-deficient mice with VSL#3 resulted in normalization of colonic physiologic function and barrier integrity in conjunction with a reduction in mucosal secretion of tumor necrosis factor α and interferon γ and an improvement in histologic disease. In vitro studies showed that epithelial barrier function and resistance to Salmonella invasion could be enhanced by exposure to a proteinaceous soluble factor secreted by the bacteria found in the VSL#3 compound. Conclusions: Oral administration of VSL#3 was effective as primary therapy in IL-10 gene-deficient mice, and had a direct effect on epithelial barrier function.
      GASTROENTEROLOGY 2001;121:580-591

      Abbreviations:

      cfu (colony-forming unit), CM (conditioned media), ELISA (enzyme-linked immunosorbent assay), G (tissue ion conductance), IFN-γ (interferon γ), IL (interleukin), Isc (short-circuit current), LPS (lipopolysaccharide), TNF-α (tumor necrosis factor α)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gui GP
        • Thomas PR
        • Tizard ML
        • Lake J
        • Sanderson JD
        • Hermon-Taylor J
        Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics.
        J Antimicrob Chemother. 1997; 39: 393-400
        • Oberhelman HA
        • Kohatsu S
        • Taylor KB
        • Kivel RM
        Diverting ileostomy in the surgical management of Crohn's disease.
        Am J Surg. 1968; 115: 231-241
        • Sutherland L
        • Singleton J
        • Sessions J
        • Hanauer S
        • Krawitt E
        • Rankin G
        • Summers R
        • Mekhjian H
        • Greenberger N
        • Kelly M
        Double-blind placebo controlled trial of metronidazole in Crohn's disease.
        Gut. 1991; 32: 1071-1075
        • Contractor NV
        • Bassiri H
        • Reya T
        • Park AY
        • Baumgart DC
        • Wasik MA
        • Emerson SG
        • Carding SR
        Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.
        J Immunol. 1998; 160: 385-394
        • Sellon RK
        • Tonkonogy SL
        • Schultz M
        • Dieleman LA
        • Grenther W
        • Balish E
        • Rennick D
        • Sartor RB
        Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.
        Infect Immun. 1998; 66: 5224-5231
        • Dianda L
        • Hanby AM
        • Wright NA
        • Sebesteny A
        • Hayday AC
        • Owen MJ
        T cell receptor-αβ- deficient mice fail to develop colitis in the absence of a microbial environment.
        Am J Pathol. 1997; 150: 91-97
        • Fuller R
        Probiotics in man and animals.
        J Appl Bacteriol. 1989; 66: 365-378
        • Gorbach SL
        • Chang TW
        • Goldin B
        Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG.
        Lancet. 1987; 2: 1519
        • Saavedra JM
        • Abi-Hanna A
        Clinical studies of probiotic agents.
        in: Probiotics. Other nutritional factors, and intestinal microflora. Lippincott-Raven, Philadelphia, PA1999: 271-286
        • Vanderhoof JA
        • Whitney DB
        • Antonson KL
        • Hanner Tl
        • Lupo JB
        • Young RJ
        Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.
        J Pediatr. 1999; 135: 564-568
        • McFarland LV
        • Surawicz CM
        • Greenberg RN
        • Elmer GW
        • Moyer KA
        • Melcher SA
        • Bowen KE
        • Cox JL
        Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
        Am J Gastroenterol. 1995; 90: 439-448
        • Neish AS
        • Gewirtz AT
        • Zeng H
        • Young AN
        • Hobert ME
        • Karmali V
        • Rao AS
        • Madara JL
        Prokaryotic regulation of epithelial responses by inhibition of IκB–a ubiquitination.
        Science. 2000; 289: 1560-1563
        • O'Mahony L
        • Feeney M
        • MacSharry J
        • Kiely B
        • McCarthy J
        • O'Sullivan GC
        • Shanahan F
        • Collins JK
        Probiotics, mononuclear cells, and epithelial cells: an anti-inflammatory network (abstr).
        Gastroenterology. 2000; 118: A680
        • Schultz M
        • Linde H
        • Staudner H
        • Lehn N
        • Falk W
        • Schoelmerich J
        Oral administration of Lactobacillus GG induces an anti-inflammatory, Th2 mediated systemic immune response towards intestinal organisms (abstr).
        Gastroenterology. 2000; 118: A4180
        • Mack DR
        • Michail S
        • Wei S
        • McDougall L
        • Hollingsworth MA
        Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
        Am J Physiol. 1999; 276: G941-G950
        • Isolauri E
        • Marjamaa H
        • Arvola T
        • Rantala I
        • Virtanen E
        • Arvilommi H
        Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats.
        Gastroenterology. 1993; 105: 1643-1650
        • Gionchetti P
        • Rizzello F
        • Venturi A
        • Brigidi P
        • Matteuzzi D
        • Bazzocchi G
        • Poggioli G
        • Miglioli M
        • Campieri M
        Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.
        Gastroenterology. 2000; 119: 305-309
        • Venturi A
        • Gionchetti P
        • Rizzello F
        • Johansson R
        • Zucconi E
        • Brigidi P
        • Matteuzzi D
        • Campiere M
        Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.
        Aliment Pharmacol Ther. 1999; 13: 1103-1108
        • Campierei M
        • Rizzello F
        • Venturi A
        • Poggioli G
        • Ugolini F
        • Helwig U
        • Amadini C
        • Romboli E
        • Gionchetti P
        Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine (abstr).
        Gastroenterology. 2000; 118: A4179
        • Kuhn R
        • Lohler J
        • Rennick D
        • Rajewsky K
        • Muller W
        Interleukin-10-deficient mice develop chronic enterocolitis.
        Cell. 1993; 75: 263-274
        • Madsen KL
        • Doyle JS
        • Jewell LD
        • Tavernini MM
        • Fedorak RN
        Lactobacillus species prevents colitis in Interleukin-10 gene-deficient mice.
        Gastroenterology. 1999; 116: 1107-1114
        • Madsen KL
        • Doyle JS
        • Tavernini MM
        • Jewell LD
        • Rennie RP
        • Fedorak RN
        Antibiotic therapy attenuates colitis in Interleukin-10 gene-deficient mice.
        Gastroenterology. 2000; 118: 1094-1105
        • Clarkson TW
        • Toole SR
        Measurement of short-circuit current and ion transport across the ileum.
        Am J Physiol. 1964; 206: 658-668
        • Saverymuttu SH
        • Camilleri M
        • Rees H
        • Lavender JP
        • Hodgson HJ
        • Chadwick VS
        Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and faecal indium 111-granulocyte excretion.
        Gastroenterology. 1986; 90: 1121-1128
        • Link H
        • Rochat F
        • Saudan KY
        • Schiffrin E
        Immunomodulation of the gnotobiotic mouse through colonization with lactic acid bacteria.
        Adv Exp Med Biol. 1995; 371A: 465-467
        • Madara JL
        • Stafford J
        Interferon-gamma directly affects barrier function of cultured intestinal epithelial.
        J Clin Invest. 1989; 83: 724-727
        • Taylor CT
        • Dzus AL
        • Colgan SP
        Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor α.
        Gastroenterology. 1998; 114: 657-668
        • Bell CJ
        • Gall DG
        • Wallace JL
        Disruption of colonic electrolyte transport in experimental colitis.
        Am J Physiol. 1995; 268: G622-G630
        • Hawker PC
        • McKay JS
        • Turnberg LA
        Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease.
        Gastroenterology. 1980; 79: 508-511
        • Madsen KL
        • Malfair DM
        • Gray D
        • Doyle JS
        • Jewell LD
        • Fedorak RN
        Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora.
        Inflamm Bowel Dis. 1999; 5: 262-270
        • Goldstein NS
        • Gyorfi T
        Focal lymphocytic colitis and collagenous colitis: patterns of Crohn's colitis.
        Am J Surg Pathol. 1999; 23: 1075-1081
        • Heinemann C
        • van Hylckama Vlieg JE
        • Janssen DB
        • Busscher HJ
        • van der Mei HC
        • Reid G
        Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131.
        FEMS Microbiol Lett. 2000; 190: 177-180
        • Jung HC
        • Eckmann L
        • Yang SD
        • Panja A
        • Fierer J
        • Morzycka-Wroblewska E
        • Kagnoff MF
        A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.
        J Clin Invest. 1995; 95: 55-65
        • Onderdonk AB
        Intestinal microflora and inflammatory bowel disease.
        in: Inflammatory bowel disease. Saunders, Philadelphia, PA2000: 144-153
        • Schultz M
        • Veltkamp C
        • Dieleman LA
        • Wyrick PB
        • Tonkonogy SL
        • Sartor RB
        Continuous feeding of Lactobacillus plantarum attenuates established colitis in Interleukin-10 deficient mice (abstr).
        Gastroenterology. 1998; 114: A426
        • Ouwehand AC
        • Isolauri E
        • Kirjavainen PV
        • Tolkko S
        • Salminen SJ
        The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. Delbrueckii subsp. Bulgaricus.
        Lett Appl Microbiol. 2000; 30: 10-13
        • Erickson KL
        • Hubbard NE
        Probiotic immunomodulation in health and disease.
        J Nutr. 2000; 130: 403S-409S
        • Haller D
        • Bode C
        • Hammes WP
        • Pfeifer AMA
        • Schiffrin EJ
        • Blum S
        Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures.
        Gut. 2000; 47: 79-87
        • Herias MV
        • Hessle C
        • Telemo E
        • Midtvedt T
        • Hanson LA
        • Wold AE
        Immunomodulatory effects of Lactobacillus plantarium colonizing the intestine of gnotobiotic rats.
        Clin Exp Immunol. 1999; 116: 283-290
        • Helgeland L
        • Vaage JT
        • Rolstad B
        • Midtvedt T
        • Brandtzaeg P
        Microbial colonization influences composition and T-cell receptor V beta repetoire of intraepithelial lymphocytes in rat intestine.
        Immunology. 1996; 89: 494-501
        • Berg DJ
        • Davidson N
        • Kuhn R
        • Muller W
        • Menon S
        • Holland G
        • Thompson-Snipes L
        • Leach MW
        • Rennick D
        Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
        J Clin Invest. 1996; 98: 1010-1020